« Medical professionals raise avian flu awareness | Main | CSU Needs Veterinarians For Bird Flu Samples »
June 16, 2006
MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
Medical News Today reports MedImmune, Inc. (Nasdaq: MEDI) announced today that the National Institutes of Health (NIH) has begun enrolling participants in a Phase 1 study of an intranasal H5N1 influenza vaccine candidate based on the company's live, attenuated vaccine technology. Investigators at MedImmune and Johns Hopkins Bloomberg School of Public Health Center for Immunization Research, where the study will be conducted, are hopeful that a live, attenuated intranasal influenza vaccine would be as effective against potential pandemic A strains as it has been shown to be against seasonal A strains of influenza.
http://www.medicalnewstoday.com/medicalnews.php?newsid=45286
Posted by sball at June 16, 2006 06:30 AM